---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-036149"
form_type: "8-K"
ticker: "SCNX"
cik: "0001382574"
company_name: "Scienture Holdings, Inc."
filed_at: "2022-12-21T23:59:59+00:00"
generated_at: "2026-06-21T00:44:17.813273+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# TRxADE HEALTH stockholders approve issuance of up to 2,663,045 shares upon exercise of warrants

## Summary
- Special Meeting held Dec 20, 2022; quorum of 59.8% of outstanding shares present.
- Proposal 1 approved: issuance of up to 2,663,045 common shares upon exercise of Private Placement Warrants.
- Approved by ~99.7% of votes cast; 5,557,740 for, 11,610 against, 2,640 abstentions.
- Proposal 2 (adjournment) also approved but not needed as Proposal 1 passed.

## SEC filing metadata
- accession: 0001493152-22-036149
- form_type: 8-K
- ticker: SCNX
- cik: 0001382574
- company_name: Scienture Holdings, Inc.
- filed_at: 2022-12-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1382574/000149315222036149/0001493152-22-036149-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1382574/000149315222036149/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-036149
- JSON: https://secwatch.observer/filing/0001493152-22-036149.json
- Plain text: https://secwatch.observer/filing/0001493152-22-036149.txt

## Key facts
- Shareholder Votes
  Scienture Holdings, Inc. shareholders approved Approval of issuance of up to 2,663,045 shares of common stock upon exercise of Private Placement Warrants at the 2022-12-20 meeting.
  - Outcome: passed
  - Meeting: 2022-12-20
  source text: 1. Proposal No. 1: To approve the issuance of up to 2,663,045 shares of our common stock upon exercise of an outstanding common stock purchase warrant (the “ Private Placement Warrants ”), in accordance with the Nasdaq Listing Rules (the “ Warrant Share Issuance Proposal ”): For Against Abstentions Broker Non-Votes 5,557,740 11,610 2,640 0 Proposal No. 1 was approved by approximately 99.7% of the aggregate total of shares of common stock voted at the Special Meeting, and as such Proposal No. 1 was approved by the stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000149315222036149/0001493152-22-036149-index.htm
- Shareholder Votes
  Scienture Holdings, Inc. shareholders approved Adjournment of Special Meeting if necessary to solicit additional proxies at the 2022-12-20 meeting.
  - Outcome: passed
  - Meeting: 2022-12-20
  source text: 2. Proposal No. 2: To approve an adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the proposal to approve the Warrant Share Issuance Proposal: For Against Abstentions Broker Non-Votes 5,519,397 48,893 2,700 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000149315222036149/0001493152-22-036149-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.